Technical Analysis for ANEB - Anebulo Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 2.36 | 3.51% | 0.08 |
ANEB closed up 3.51 percent on Wednesday, May 15, 2024, on 2.5 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 200 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% |
| Alert | Time |
|---|---|
| 200 DMA Resistance | about 16 hours ago |
| 20 DMA Resistance | about 16 hours ago |
| Rose Above Previous Day's High | about 16 hours ago |
| Rose Above 200 DMA | about 16 hours ago |
| 50 DMA Resistance | about 16 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well tolerated and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.05 |
| 52 Week Low | 1.62 |
| Average Volume | 5,984 |
| 200-Day Moving Average | 2.63 |
| 50-Day Moving Average | 2.75 |
| 20-Day Moving Average | 2.80 |
| 10-Day Moving Average | 2.82 |
| Average True Range | 0.25 |
| RSI (14) | 35.06 |
| ADX | 29.72 |
| +DI | 24.37 |
| -DI | 31.49 |
| Chandelier Exit (Long, 3 ATRs) | 2.56 |
| Chandelier Exit (Short, 3 ATRs) | 2.94 |
| Upper Bollinger Bands | 3.26 |
| Lower Bollinger Band | 2.35 |
| Percent B (%b) | 0.01 |
| BandWidth | 32.46 |
| MACD Line | -0.06 |
| MACD Signal Line | 0.02 |
| MACD Histogram | -0.0754 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.21 | ||||
| Resistance 3 (R3) | 3.27 | 3.04 | 3.07 | ||
| Resistance 2 (R2) | 3.04 | 2.82 | 3.01 | 3.02 | |
| Resistance 1 (R1) | 2.70 | 2.69 | 2.59 | 2.64 | 2.97 |
| Pivot Point | 2.48 | 2.48 | 2.42 | 2.45 | 2.48 |
| Support 1 (S1) | 2.14 | 2.26 | 2.02 | 2.08 | 1.75 |
| Support 2 (S2) | 1.91 | 2.13 | 1.88 | 1.70 | |
| Support 3 (S3) | 1.57 | 1.91 | 1.65 | ||
| Support 4 (S4) | 1.51 |
